Non-invasive TRanscutaneous Cervical Vagus Nerve Stimulation as a Treatment for Acute Stroke; Safety and Feasibility Study

The requested reference [03c942e7a69d0353fc76157f85409a568e2ed752] no longer exists in our database. It has been replaced by the current reference: [693f2889cb25ed50011dc28866a7264d74651344]

Authors Turkish Stroke Research and Clinical Trials Network -More
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Links ClinicalTrials.gov
This study aims to determine safety and feasibility of non‐invasive transcutaneous cervical Vagus nerve stimulation (nVNS) when delivered promptly after clinical diagnosis of acute stroke. Vagus nerve stimulation will be performed via GammaCore® device. A total of 60 patients will be randomized to each of 3 different groups; 'standard dose' vagal stimulation, 'high dose' vagal stimulation, and 'sham stimulation' (1:1:1 ratio). Adverse device events, serious adverse device events, and feasibility of vagal nerve stimulation at the setting of acute stroke will be evaluated. The study will be performed in a multi‐center fashion among stroke centers within TurkStrokeNet Network.
Epistemonikos ID: 5d869f9ec2a8d44f24f0efd0359f92cd87800cdd
First added on: May 21, 2024